Crinetics Pharmaceuticals, Inc (CRNX) insider trading
Every open-market stock purchase and sale by Crinetics Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $6.5M over the last 12 months (12 sales). No open-market buys.
- Last insider buy: Coelho Rogerio Vivaldi (Director), $110K, 3 years ago.
- Congress: Gilbert Cisneros sold $15K to $50K, 3 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $6.5M (12 sales). Last close $84.95 on Aug 31, 2026.
Recent CRNX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $21.1M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $18.8M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $18.1M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $15.9M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $15.1M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $15M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $12.2M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $11.6M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $10.3M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $10M |
| Sep 1, 2026 | Wendell Wierenga (Director) | Sold (not open market) | $9.9M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $9.4M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $9.4M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $9.3M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $9M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $8.5M |
| Sep 1, 2026 | Stephen F. Betz (C-suite exec) | Sold (not open market) | $7.5M |
| Sep 1, 2026 | Stephen F. Betz (C-suite exec) | Sold (not open market) | $7.2M |
| Sep 1, 2026 | Richard Scott Struthers (CEO) | Sold (not open market) | $6.8M |
| Sep 1, 2026 | Stephen F. Betz (C-suite exec) | Sold (not open market) | $6.8M |
| Sep 1, 2026 | Tobin Schilke (CFO) | Sold (not open market) | $6.1M |
| Sep 1, 2026 | Stephen F. Betz (C-suite exec) | Sold (not open market) | $5.9M |
| Sep 1, 2026 | Stephen F. Betz (C-suite exec) | Sold (not open market) | $5.6M |
| Sep 1, 2026 | Stephen F. Betz (C-suite exec) | Sold (not open market) | $5M |
| Sep 1, 2026 | Stephen F. Betz (C-suite exec) | Sold (not open market) | $5M |
Who's trading CRNX
- Camille L Bedrosian, Director: other filings, last Sep 1, 2026
- Stephen F. Betz, C-suite exec: sold $397K (2 sales), last Sep 1, 2026
- Caren Deardorf, Director: other filings, last Sep 1, 2026
- Matthew K Fust, Director: other filings, last Sep 1, 2026
- Isabel Kalofonos, C-suite exec: sold $138K (1 sale), last Sep 1, 2026
- Weston Nichols, Director: other filings, last Sep 1, 2026
- Stephanie Okey, Director: sold $365K (3 sales), last Sep 1, 2026
- Tobin Schilke, CFO: sold $266K (1 sale), last Sep 1, 2026
- Richard Scott Struthers, CEO: sold $822K (2 sales), last Sep 1, 2026
- Coelho Rogerio Vivaldi, Director: sold $301K (3 sales), last Sep 1, 2026
- Wendell Wierenga, Director: other filings, last Sep 1, 2026
- Gilbert Cisneros, Representative: bought $8K (1 buy), sold $15K (1 sale), last Jul 30, 2026
- Jeff E. Knight, COO: sold $3.8M (3 sales), last Apr 8, 2026
- Dana Pizzuti, Officer: sold $438K (3 sales), last Dec 1, 2025
Get free alerts when an insider at Crinetics Pharmaceuticals, Inc files a new trade →